Over the past years we have covered diverse topics: vaccination, oncology breakthroughs, a healthy lifestyle, prevention of smoking, orphan drugs and many more. The common thread in our work? To bring stakeholders together. Through thoughtful positioning, impactful communication and interactive events – both small and large. Our team is well equipped to dive into each topic and context as it consists of professionals with roots in life sciences, public health, policy making, communication and public perception. Our mission — to contribute to a healthy and sustainable world — guides us in our day-to-day work. 

Understanding the landscape and the people in it 

One of our strengths lies in knowing the field. Not just the technologies or the regulations, but the people. We understand the dynamics of biomedical professionals, the expectations of policymakers, and the concerns of patients and the public. That insight allows us to help organizations position themselves — not just in terms of what they do, but why it matters. 

Take the launch of Oncode Accelerator. We helped shape Oncode Accelerator not just as a brand, but as an initiative that connects scientific excellence with societal relevance. By crafting a clear narrative, designing a strong visual identity, and bringing together key stakeholders for a festive launch, we helped build a force in oncology innovation. 

Building bridges that lead to action 

Meaningful innovation doesn’t happen in isolation. To have societal impact, innovators require trust, dialogue, and shared direction with the societies they work in. That’s why stakeholder engagement is at the heart of our work since our inception in 1995. After 30 years, we see it’s time to go back to these roots. In a polarizing society, it’s more important than ever to reconnect business and society. S&P helps its clients with making progress. Not only from our headquarters in The Netherlands, but also internationally from our office in Brussels. And these efforts deliver results. 

A recent example is our work with the Association for Innovative Medicines (VIG) on orphan medicines. These treatments often face complex developmental, regulatory and reimbursement hurdles, and their societal value is not always well understood. We brought together patient representatives, policymakers, healthcare professionals, researchers, payers and industry representatives to explore shared solutions. Not through one-off meetings, but through a structured engagement process of several years that has led to concrete steps forward, recommendations, and renewed momentum. Visit www.weesgeneesmiddelen.nl to learn more about this initiative. 

Sustainability: from compliance to impact 

Health and sustainability are deeply connected. In the Netherlands, about 7% of the national carbon footprint comes from the healthcare sector.

At the same time, climate change and nature degradation increasingly threaten global health — through extreme weather, shifting disease patterns, and the loss of ecosystems that support wellbeing. We believe the healthcare sector has both the responsibility and the opportunity to lead. Society expects more than medical safety and efficacy; it calls for visible commitment to reducing environmental impact. We help organizations respond by shaping ESG strategies and conducting environmental impact assessments. 

Take ESG reporting. While the CSRD has brought complexity and delay, we see reporting not as a burden but as a strategic tool. Done well, it informs decisions, builds trust, and connects companies to the broader societal transition. We support clients with sector-specific insight and environmental expertise.

Together with Healthbridgers, we’ve built the capacity to conduct life cycle assessments of pharmaceutical products and diagnostics.

These assessments quantify carbon footprints, reveal nature-related dependencies, and identify reduction hotspots — turning data into action for a more sustainable healthcare system. 

A story that moves forward 

What ties our work together is a commitment to clarity, connection, and collective progress. Whether we’re helping an innovative organization find its voice, facilitating dialogue on rare diseases, or calculating the environmental footprint of a new therapy — we approach each challenge with a cool head, a sharp pen, and a clear purpose. In a world full of opinions, we anchor ourselves in facts. In a sector full of complexity, we help bring clarity. And in a time of rapid change, we offer direction. 

Want to move forward? 

Whether you're developing breakthrough therapies, navigating ESG regulations, or seeking to engage stakeholders meaningfully — we’re here to help. Let’s reconnect and build a healthier, more